Catalyst Wire Dossier Catalyst Wire Dossier

Pomalidomide Teva

pomalidomide · Teva GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pomalidomide Teva, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: EMA Authorised: Pomalidomide Teva (Pomalidomide) — Teva GmbH

See pricing